An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis

Epilepsia

Volumn 57, Issue 1, 2016, Pages 41-50

  De Kinderen, Reina J A ^a,b,c   Lambrechts, Danielle A J E ^d   Wijnen, Ben F M ^a   Postulart, Debby ^b   Aldenkamp, Albert P ^b,c,d   Majoie, Marian H J M ^b,d,e   Evers, Silvia M A A ^a,f  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^f NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

Author keywords

Cost effectiveness; Cost utility; Economic evaluation; Ketogenic diet; Quality of life

Indexed keywords

ADOLESCENT; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIET THERAPY; DRUG RESISTANT EPILEPSY; ECONOMICS; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INFANT; KETOGENIC DIET; MALE; PRESCHOOL CHILD; PROCEDURES; PSYCHOLOGY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DRUG RESISTANT EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; INFANT; KETOGENIC DIET; MALE; QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES;

EID: 84954078275     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13254     Document Type: Article

References (40)

1. Strzelczyk A, Reese JP, Dodel R, et al., Cost of epilepsy: a systematic review. Pharmacoeconomics 2008; 26: 463-476.
2. Wallace H, Shorvon S, Tallis R,. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998; 352: 1970-1973.
3. Pugliatti M, Beghi E, Forsgren L, et al., Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 2007; 48: 2224-2233.
4. Slobbe LCJ, Smit JM, Groen J, et al., Cost of illness in the Netherlands 2007: trends in healthcare expenditure 1999-2010. Bilthoven: RIVM; 2011.
5. Sillanpaa M, Schmidt D,. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 2006; 129: 617-624.
6. Freeman J, Veggiotti P, Lanzi G, et al., The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res 2006; 68: 145-180.
7. MatthewsFriends. 4th Global symposium for Dietary Thearpies for Epilepsy and other Neurological Disorders for Health Care Professionals Liverpool; 2014.
8. Caraballo RH, Cersosimo RO, Sakr D, et al., Ketogenic diet in patients with Dravet syndrome. Epilepsia 2005; 46: 1539-1544.
9. Coppola G, Veggiotti P, Cusmai R, et al., The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res 2002; 48: 221-227.
10. Freeman JM, Vining EP, Pillas DJ, et al., The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998; 102: 1358-1363.
11. Kang HC, Kim YJ, Kim DW, et al., Efficacy and safety of the ketogenic diet for intractable childhood epilepsy: Korean multicentric experience. Epilepsia 2005; 46: 272-279.
12. Kankirawatana P, Jirapinyo P, Kankirawatana S, et al., Ketogenic diet: an alternative treatment for refractory epilepsy in children. J Med Assoc Thai 2001; 84: 1027-1032.
13. Kossoff EH, Pyzik PL, McGrogan JR, et al., Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002; 109: 780-783.
14. Maydell BV, Wyllie E, Akhtar N, et al., Efficacy of the ketogenic diet in focal versus generalized seizures. Pediatr Neurol 2001; 25: 208-212.
15. Vining EP,. Clinical efficacy of the ketogenic diet. Epilepsy Res 1999; 37: 181-190.
16. Keene DL,. A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol 2006; 35: 1-5.
17. Lefevre F, Aronson N,. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics 2000; 105: E46.
18. Sinha SR, Kossoff EH,. The ketogenic diet. Neurologist 2005; 11: 161-170.
19. Levy RG, Cooper PN, Giri P,. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev 2012; 3: CD00190.
20. Neal EG, Chaffe H, Schwartz RH, et al., The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008; 7: 500-506.
21. Sharma S, Sankhyan N, Gulati S, et al., Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 2013; 54: 481-486.
22. Drummond MF, Sculpher MJ, Torrance GW, et al., Methods for the economic evaluation of health care programs. Oxford: Oxford University Press; 2005.
23. Ligtenberg G, Staal PC, Goettsch WG, et al., Cost-effectiveness in health care. Diemen: National Health Care Institute; 2013.
24. de Kinderen RJ, Lambrechts DA, Postulart D, et al., Research into the (cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. BMC Neurol 2011; 11: 10.
25. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
26. Wille N, Badia X, Bonsel G, et al., Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res 2010; 19: 875-886.
27. Lamers LM, McDonnell J, Stalmeier PF, et al., The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006; 15: 1121-1132.
28. Fekkes M, Theunissen NC, Brugman E, et al., Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res 2000; 9: 961-972.
29. Vogels T, Verrips GH, Koopman HM,. TACQOL manual. Parent form and child form. Leiden: Leiden Center for Child Health and Pediatrics LUMC-TNO; 2000.
30. Goossens ME, Rutten-van Molken MP, Vlaeyen JW, et al., The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53: 688-695.
31. van Hakkaart-Roijen L, Tan SS, Bouwmans CAM,. Guideline for costing studies (in Dutch). Amstelveen: CVZ; 2010.
32. Council for Public Health and Health Care. Sensible and sustainable care (in Dutch). Zoetermeer: Council for Public Health and Health Care; 2006.
33. Salomon JA, Vos T, Hogan DR, et al., Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2129-2143.
34. NICE. The guidelines manual. Process and methods guides. London: National Institute for Health and Care Excellence; 2012.
35. Campo SF, Sharpton WR, Thompson B, et al., Measurement characteristics of the Quality of Life Index when used with adults who have severe mental retardation. Am J Ment Retard 1996; 100: 546-550.
36. Birbeck GL, Hays RD, Cui X, et al., Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 2002; 43: 535-538.
37. Stevens K, Ratcliffe J,. Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. Value Health 2012; 15: 1092-1099.
38. Richardson JR, Peacock SJ, Hawthorne G, et al., Construction of the descriptive system for the Assessment of Quality of Life AQoL-6D utility instrument. Health Qual Life Outcomes 2012; 10: 38.
39. de Kinderen RJ, Postulart D, Aldenkamp AP, et al., Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy. Epilepsy Res 2015; 110: 119-131.
40. Mackay MT, Bicknell-Royle J, Nation J, et al., The ketogenic diet in refractory childhood epilepsy. J Paediatr Child Health 2005; 41: 353-357.